Journal article
Folliculotropic mycosis fungoides responding to bexarotene gel
Journal of drugs in dermatology, Vol.7(2), pp.169-171
02/2008
PMID: 18335654
Abstract
Folliculotropic mycosis fungoides (FMF) is an uncommon and potentially aggressive form of cutaneous T cell lymphoma (CTCL). Phototherapy, radiotherapy, and systemic chemotherapy are the most commonly employed treatment options, but may have limited success and common adverse reactions. Bexarotene gel is a topical retinoid X receptor (RXR) agonist with activity on the follicular unit that has not been previously reported in the management of FME The case of a 73-year-old male with FMF that responded to bexarotene gel is presented.
Details
- Title: Subtitle
- Folliculotropic mycosis fungoides responding to bexarotene gel
- Creators
- Hobart W Walling - Town Square Dermatology, Coralville, IA 52241, USA. hobartwalling@yahoo.comBrian L SwickPedram GeramiRichard K Scupham
- Resource Type
- Journal article
- Publication Details
- Journal of drugs in dermatology, Vol.7(2), pp.169-171
- Publisher
- United States
- PMID
- 18335654
- ISSN
- 1545-9616
- Language
- English
- Date published
- 02/2008
- Academic Unit
- Dermatology; Pathology
- Record Identifier
- 9984025401602771
Metrics
11 Record Views